Pharma
0
Innocan Pharma revenue skyrockets, but bottom line still in the red
0

Innocan Pharma revenue skyrockets, but bottom line still in the red

The company also completed a $1.5 million capital raise just last month to help propel it through 2024.Canada-based tech firm Innocan Pharma Corp. (CSE: ...

reviewer4you.com reviewer4you.com 2 April 2024
READ MORE +
0
Your Cart is empty!

It looks like you haven't added any items to your cart yet.

Browse Products
Powered by Caddy